Xatral Lp Tablets 10Mg

Product Overview

Product Form: Tablet
Pack Size: 1x30's tablet
Manufactured By: Sanofi Aventis
Prescription Required: Yes

Product Details

Xatral LP Tablets 10mg is a specialized treatment for benign prostatic hyperplasia (BPH), produced by Sanofi Aventis. The active ingredient, Alfuzosin, works by selectively blocking alpha1-adrenergic receptors in the lower urinary tract. This action helps relax the smooth muscles in the prostate and bladder neck, improving urinary flow and reducing BPH symptoms. The extended-release formulation ensures steady medication levels, providing effective relief over time.

Purposes

Xatral LP Tablets are primarily used to alleviate the symptoms of benign prostatic hyperplasia (BPH), including urinary frequency, nocturia, weak urine stream, and hesitancy. Additionally, Xatral LP can be used as an adjunctive treatment for acute urinary retention related to BPH, especially in the management following catheter removal.

Warnings

Xatral Tablets should be used with caution in patients with a history of orthostatic hypotension or those on antihypertensive medications. The risk of priapism, a condition of persistent and painful erections, is present and requires immediate medical attention if it occurs. Patients with a history of tachyarrhythmia or cardiovascular conditions should be closely monitored. Avoid using Xatral tabs in combination with other alpha1-blockers or potent CYP3A4 inhibitors due to potential interactions.

Adverse Effects

Common side effects of Xatral LP 10mg include dizziness, headache, nausea, and abdominal pain. Other potential effects are postural hypotension, tachycardia, and drowsiness. Less frequent but serious reactions may involve rash, water retention, and visual disturbances. If any severe or persistent side effects occur, consult your healthcare provider promptly.

Cautions

When using Xatral LP Tablets, exercise caution in patients with symptomatic orthostatic hypotension or those who have experienced pronounced hypotensive responses to other medications. Regular monitoring is advised for patients with cardiovascular conditions or those at risk of QTc prolongation. Ensure to follow the prescribed dosage and avoid interactions with other medications that may affect the efficacy or safety of Xatral.